BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 17691158)

  • 1. House says "yes" to Medicare Part D price negotiations, passes legislation.
    Consult Pharm; 2007 Mar; 22(3):254. PubMed ID: 17691158
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare should bargain for lower drug prices, study says.
    Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward a rational, value-based drug benefit for Medicare.
    Lopert R; Moon M
    Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 9. US budget battle is likely to rekindle fight over drug price negotiations for Medicare prescriptions.
    McCarthy M
    BMJ; 2015 Jan; 350():h567. PubMed ID: 25636308
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspectives. Imagine health care swallowing 50 percent of GDP.
    Med Health; 2004 Apr; 58(15):1, 7-8. PubMed ID: 15112422
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives. E-prescribing, formularies play big roles in Rx bill. 2.
    Med Health; 2003 Dec; 57(45):1, 7-8. PubMed ID: 14723167
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare part D--what doctors need to know.
    Stephenson L
    Iowa Med; 2005; 95(6):24-5. PubMed ID: 16425707
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare Part D--the product of a broken process.
    Slaughter LM
    N Engl J Med; 2006 Jun; 354(22):2314-5. PubMed ID: 16738267
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare Program; revisions to the Medicare Advantage and Prescription Drug Benefit programs. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54225-54. PubMed ID: 18985953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part D decisions: like other employers, many states are collecting a new federal subsidy for maintaining retiree drug coverage--but for many, that's not their "final answer".
    Burton R; Folkemer D
    State Legis; 2006 Sep; 32(8):26-7. PubMed ID: 16958187
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-19. PubMed ID: 20213917
    [No Abstract]   [Full Text] [Related]  

  • 20. Federally negotiated drug prices anticipated for Medicare Part D.
    Sipkoff M
    Manag Care; 2006 Dec; 15(12):19-20. PubMed ID: 17260839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.